Cargando…

Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277573/
https://www.ncbi.nlm.nih.gov/pubmed/34277459
http://dx.doi.org/10.3389/fonc.2021.721658
_version_ 1783722101312585728
collection PubMed
description
format Online
Article
Text
id pubmed-8277573
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82775732021-07-15 Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway Front Oncol Oncology Frontiers Media S.A. 2021-06-29 /pmc/articles/PMC8277573/ /pubmed/34277459 http://dx.doi.org/10.3389/fonc.2021.721658 Text en Copyright © 2021 Frontiers Editorial Office https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
title Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
title_full Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
title_fullStr Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
title_full_unstemmed Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
title_short Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
title_sort retraction: combination of tanshinone iia and cisplatin inhibits esophageal squamous cell carcinoma by down-regulating nf-kb/cox-2/vegf pathway
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277573/
https://www.ncbi.nlm.nih.gov/pubmed/34277459
http://dx.doi.org/10.3389/fonc.2021.721658
work_keys_str_mv AT retractioncombinationoftanshinoneiiaandcisplatininhibitsesophagealsquamouscellcarcinomabydownregulatingnfkbcox2vegfpathway